Nerve injuries present a substantial challenge within the medical domain due to
their prevalent occurrence and significant impact. In nerve injuries, a range of
physiopathological and metabolic responses come into play to stabilize and
repair the resulting damage. A critical concern arises from the disruption of
connections at neuromuscular junctions, leading to profound degeneration and
substantial loss of muscle function, thereby hampering motor tasks. While
end-to-end neurorrhaphy serves as the established technique for treating
peripheral nerve injuries, achieving comprehensive morphofunctional recovery
remains a formidable challenge. In pursuit of enhancing the repair process,
alternative and supportive methods are being explored. A promising candidate is
the utilization of heterologous fibrin biopolymer, a sealant devoid of human
blood components. Notably, this biopolymer has showcased its prowess in
establishing a stable and protective microenvironment at the site of use in
multiple scenarios of regenerative medicine. Hence, this scoping review is
directed towards assessing the effects of associating heterologous fibrin
biopolymer with neurorrhaphy to treat nerve injuries, drawing upon findings from
prior studies disseminated through PubMed/MEDLINE, Scopus, and Web of Science
databases. Further discourse delves into the intricacies of the biology of
neuromuscular junctions, nerve injury pathophysiology, and the broader
utilization of fibrin sealants in conjunction with sutures for nerve
reconstruction procedures. The association of the heterologous fibrin biopolymer
with neurorrhaphy emerges as a potential avenue for surmounting the limitations
associated with traditional sealants while also mitigating degeneration in
nerves, muscles, and NMJs post-injury, thereby fostering a more conducive
environment for subsequent regeneration. Indeed, queries arise regarding the
long-term regenerative potential of this approach and its applicability in
reconstructive surgeries for human nerve injuries.